NZ research industry body appoints new chair
This article was originally published in Scrip
Executive Summary
New Zealand's pharmaceutical trade body, the Researched Medicines Industry (RMI), has appointed Lex Henry as its new chairman. Mr Henry is currently chair of merchant bank Cranleigh, special counsel with law firm Minter Ellison Rudd Watts and director of the health software company MedTech. He will replace Dr Pippa MacKay, who resigned from the role after five years in October (scripnews.com, October 8th, 2009).